IBDEI0CW ; ; 03-MAY-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 03, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,32356,1,4,0)
;;=4^L20.89
;;^UTILITY(U,$J,358.3,32356,2)
;;=^5009112
;;^UTILITY(U,$J,358.3,32357,0)
;;=L25.9^^97^1335^15
;;^UTILITY(U,$J,358.3,32357,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32357,1,3,0)
;;=3^Contact Dermatitis,Unspec
;;^UTILITY(U,$J,358.3,32357,1,4,0)
;;=4^L25.9
;;^UTILITY(U,$J,358.3,32357,2)
;;=^5133647
;;^UTILITY(U,$J,358.3,32358,0)
;;=L40.0^^97^1335^16
;;^UTILITY(U,$J,358.3,32358,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32358,1,3,0)
;;=3^Psoriasis
;;^UTILITY(U,$J,358.3,32358,1,4,0)
;;=4^L40.0
;;^UTILITY(U,$J,358.3,32358,2)
;;=^5009160
;;^UTILITY(U,$J,358.3,32359,0)
;;=L29.9^^97^1335^17
;;^UTILITY(U,$J,358.3,32359,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32359,1,3,0)
;;=3^Pruritus
;;^UTILITY(U,$J,358.3,32359,1,4,0)
;;=4^L29.9
;;^UTILITY(U,$J,358.3,32359,2)
;;=^5009153
;;^UTILITY(U,$J,358.3,32360,0)
;;=L85.3^^97^1335^18
;;^UTILITY(U,$J,358.3,32360,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32360,1,3,0)
;;=3^Xerosis
;;^UTILITY(U,$J,358.3,32360,1,4,0)
;;=4^L85.3
;;^UTILITY(U,$J,358.3,32360,2)
;;=^5009323
;;^UTILITY(U,$J,358.3,32361,0)
;;=L30.2^^97^1335^19
;;^UTILITY(U,$J,358.3,32361,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32361,1,3,0)
;;=3^Cutaneous Autosensitization/ld
;;^UTILITY(U,$J,358.3,32361,1,4,0)
;;=4^L30.2
;;^UTILITY(U,$J,358.3,32361,2)
;;=^5009155
;;^UTILITY(U,$J,358.3,32362,0)
;;=L72.0^^97^1335^20
;;^UTILITY(U,$J,358.3,32362,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32362,1,3,0)
;;=3^Epidermal Cyst
;;^UTILITY(U,$J,358.3,32362,1,4,0)
;;=4^L72.0
;;^UTILITY(U,$J,358.3,32362,2)
;;=^5009277
;;^UTILITY(U,$J,358.3,32363,0)
;;=L73.9^^97^1335^21
;;^UTILITY(U,$J,358.3,32363,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32363,1,3,0)
;;=3^Follicular Disorder/Folliculitis
;;^UTILITY(U,$J,358.3,32363,1,4,0)
;;=4^L73.9
;;^UTILITY(U,$J,358.3,32363,2)
;;=^5009286
;;^UTILITY(U,$J,358.3,32364,0)
;;=L70.0^^97^1335^22
;;^UTILITY(U,$J,358.3,32364,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32364,1,3,0)
;;=3^Acne
;;^UTILITY(U,$J,358.3,32364,1,4,0)
;;=4^L70.0
;;^UTILITY(U,$J,358.3,32364,2)
;;=^5009268
;;^UTILITY(U,$J,358.3,32365,0)
;;=L71.8^^97^1335^23
;;^UTILITY(U,$J,358.3,32365,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32365,1,3,0)
;;=3^Rosacea
;;^UTILITY(U,$J,358.3,32365,1,4,0)
;;=4^L71.8
;;^UTILITY(U,$J,358.3,32365,2)
;;=^5009275
;;^UTILITY(U,$J,358.3,32366,0)
;;=L91.0^^97^1335^24
;;^UTILITY(U,$J,358.3,32366,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32366,1,3,0)
;;=3^Hypertrophic Scar
;;^UTILITY(U,$J,358.3,32366,1,4,0)
;;=4^L91.0
;;^UTILITY(U,$J,358.3,32366,2)
;;=^5009459
;;^UTILITY(U,$J,358.3,32367,0)
;;=L91.8^^97^1335^25
;;^UTILITY(U,$J,358.3,32367,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32367,1,3,0)
;;=3^Skin Tag/Oth Hypertrophic Disorder of Skin
;;^UTILITY(U,$J,358.3,32367,1,4,0)
;;=4^L91.8
;;^UTILITY(U,$J,358.3,32367,2)
;;=^5009460
;;^UTILITY(U,$J,358.3,32368,0)
;;=I87.2^^97^1335^26
;;^UTILITY(U,$J,358.3,32368,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32368,1,3,0)
;;=3^Stasis Dermatitis/Venous Insufficiency
;;^UTILITY(U,$J,358.3,32368,1,4,0)
;;=4^I87.2
;;^UTILITY(U,$J,358.3,32368,2)
;;=^5008047
;;^UTILITY(U,$J,358.3,32369,0)
;;=D69.8^^97^1335^27
;;^UTILITY(U,$J,358.3,32369,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32369,1,3,0)
;;=3^Purpura,Hemorrhagic Condition
;;^UTILITY(U,$J,358.3,32369,1,4,0)
;;=4^D69.8
;;^UTILITY(U,$J,358.3,32369,2)
;;=^88074
;;^UTILITY(U,$J,358.3,32370,0)
;;=L08.9^^97^1335^28
;;^UTILITY(U,$J,358.3,32370,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32370,1,3,0)
;;=3^Pyoderma
;;^UTILITY(U,$J,358.3,32370,1,4,0)
;;=4^L08.9
;;^UTILITY(U,$J,358.3,32370,2)
;;=^5009082
;;^UTILITY(U,$J,358.3,32371,0)
;;=L01.00^^97^1335^29
;;^UTILITY(U,$J,358.3,32371,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32371,1,3,0)
;;=3^Impetigo
;;^UTILITY(U,$J,358.3,32371,1,4,0)
;;=4^L01.00
;;^UTILITY(U,$J,358.3,32371,2)
;;=^5008938
;;^UTILITY(U,$J,358.3,32372,0)
;;=L03.90^^97^1335^30
;;^UTILITY(U,$J,358.3,32372,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32372,1,3,0)
;;=3^Cellulitis
;;^UTILITY(U,$J,358.3,32372,1,4,0)
;;=4^L03.90
;;^UTILITY(U,$J,358.3,32372,2)
;;=^5009067
;;^UTILITY(U,$J,358.3,32373,0)
;;=Z79.1^^97^1335^31
;;^UTILITY(U,$J,358.3,32373,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32373,1,3,0)
;;=3^Long Term Use NSAID/Oth Health Status
;;^UTILITY(U,$J,358.3,32373,1,4,0)
;;=4^Z79.1
;;^UTILITY(U,$J,358.3,32373,2)
;;=^5063332
;;^UTILITY(U,$J,358.3,32374,0)
;;=Z79.899^^97^1335^32
;;^UTILITY(U,$J,358.3,32374,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32374,1,3,0)
;;=3^Long Term Use Oth Drug
;;^UTILITY(U,$J,358.3,32374,1,4,0)
;;=4^Z79.899
;;^UTILITY(U,$J,358.3,32374,2)
;;=^5063343
;;^UTILITY(U,$J,358.3,32375,0)
;;=Z80.8^^97^1335^33
;;^UTILITY(U,$J,358.3,32375,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32375,1,3,0)
;;=3^Family Hx of Melanoma
;;^UTILITY(U,$J,358.3,32375,1,4,0)
;;=4^Z80.8
;;^UTILITY(U,$J,358.3,32375,2)
;;=^5063356
;;^UTILITY(U,$J,358.3,32376,0)
;;=Z48.817^^97^1335^34
;;^UTILITY(U,$J,358.3,32376,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32376,1,3,0)
;;=3^Surgical Aftercare Skin/Subcutaneous Tissue
;;^UTILITY(U,$J,358.3,32376,1,4,0)
;;=4^Z48.817
;;^UTILITY(U,$J,358.3,32376,2)
;;=^5063054
;;^UTILITY(U,$J,358.3,32377,0)
;;=R99.^^97^1335^35
;;^UTILITY(U,$J,358.3,32377,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32377,1,3,0)
;;=3^Dead Unknown Mortality
;;^UTILITY(U,$J,358.3,32377,1,4,0)
;;=4^R99.
;;^UTILITY(U,$J,358.3,32377,2)
;;=^5019750
;;^UTILITY(U,$J,358.3,32378,0)
;;=Z85.9^^97^1335^36
;;^UTILITY(U,$J,358.3,32378,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32378,1,3,0)
;;=3^Personal Hx of Unspec Neoplasm/Cancer
;;^UTILITY(U,$J,358.3,32378,1,4,0)
;;=4^Z85.9
;;^UTILITY(U,$J,358.3,32378,2)
;;=^5063452
;;^UTILITY(U,$J,358.3,32379,0)
;;=C79.9^^97^1335^37
;;^UTILITY(U,$J,358.3,32379,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32379,1,3,0)
;;=3^Metastatic Cancer Unspec
;;^UTILITY(U,$J,358.3,32379,1,4,0)
;;=4^C79.9
;;^UTILITY(U,$J,358.3,32379,2)
;;=^5133344
;;^UTILITY(U,$J,358.3,32380,0)
;;=Q3014^^98^1336^1^^^^1
;;^UTILITY(U,$J,358.3,32380,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,32380,1,2,0)
;;=2^Q3014
;;^UTILITY(U,$J,358.3,32380,1,3,0)
;;=3^Telehealth Fac Fee-Pt Site
;;^UTILITY(U,$J,358.3,32381,0)
;;=B19.10^^99^1337^1
;;^UTILITY(U,$J,358.3,32381,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32381,1,3,0)
;;=3^Hepatitis B w/o Hepatic Coma
;;^UTILITY(U,$J,358.3,32381,1,4,0)
;;=4^B19.10
;;^UTILITY(U,$J,358.3,32381,2)
;;=^5000552
;;^UTILITY(U,$J,358.3,32382,0)
;;=B17.10^^99^1337^2
;;^UTILITY(U,$J,358.3,32382,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32382,1,3,0)
;;=3^Hepatitis C w/o Hepatic Coma,Acute
;;^UTILITY(U,$J,358.3,32382,1,4,0)
;;=4^B17.10
;;^UTILITY(U,$J,358.3,32382,2)
;;=^5000542
;;^UTILITY(U,$J,358.3,32383,0)
;;=B18.2^^99^1337^3
;;^UTILITY(U,$J,358.3,32383,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32383,1,3,0)
;;=3^Hepatitis C,Chr
;;^UTILITY(U,$J,358.3,32383,1,4,0)
;;=4^B18.2
;;^UTILITY(U,$J,358.3,32383,2)
;;=^5000548
;;^UTILITY(U,$J,358.3,32384,0)
;;=B35.6^^99^1337^4
;;^UTILITY(U,$J,358.3,32384,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32384,1,3,0)
;;=3^Tinea Cruris
;;^UTILITY(U,$J,358.3,32384,1,4,0)
;;=4^B35.6
;;^UTILITY(U,$J,358.3,32384,2)
;;=^119711
;;^UTILITY(U,$J,358.3,32385,0)
;;=B35.3^^99^1337^5
;;^UTILITY(U,$J,358.3,32385,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32385,1,3,0)
;;=3^Tinea Pedis
;;^UTILITY(U,$J,358.3,32385,1,4,0)
;;=4^B35.3
;;^UTILITY(U,$J,358.3,32385,2)
;;=^119732
;;^UTILITY(U,$J,358.3,32386,0)
;;=B97.89^^99^1337^6
;;^UTILITY(U,$J,358.3,32386,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32386,1,3,0)
;;=3^Viral Agents as the Cause of Diseases Classified Elsewhere
;;^UTILITY(U,$J,358.3,32386,1,4,0)
;;=4^B97.89
;;^UTILITY(U,$J,358.3,32386,2)
;;=^5000879
;;^UTILITY(U,$J,358.3,32387,0)
;;=B02.9^^99^1337^7
;;^UTILITY(U,$J,358.3,32387,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32387,1,3,0)
;;=3^Zoster w/o Complications
;;^UTILITY(U,$J,358.3,32387,1,4,0)
;;=4^B02.9
;;^UTILITY(U,$J,358.3,32387,2)
;;=^5000501
;;^UTILITY(U,$J,358.3,32388,0)
;;=C44.91^^99^1338^1
;;^UTILITY(U,$J,358.3,32388,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32388,1,3,0)
;;=3^Basal cell carcinoma of skin, unspecified
;;^UTILITY(U,$J,358.3,32388,1,4,0)
;;=4^C44.91
;;^UTILITY(U,$J,358.3,32388,2)
;;=^5001092
;;^UTILITY(U,$J,358.3,32389,0)
;;=D17.9^^99^1338^2
;;^UTILITY(U,$J,358.3,32389,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32389,1,3,0)
;;=3^Benign lipomatous neoplasm, unspecified
;;^UTILITY(U,$J,358.3,32389,1,4,0)
;;=4^D17.9
;;^UTILITY(U,$J,358.3,32389,2)
;;=^5002020
;;^UTILITY(U,$J,358.3,32390,0)
;;=C67.9^^99^1338^3
;;^UTILITY(U,$J,358.3,32390,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32390,1,3,0)
;;=3^Malignant neoplasm of bladder, unspecified
;;^UTILITY(U,$J,358.3,32390,1,4,0)
;;=4^C67.9
;;^UTILITY(U,$J,358.3,32390,2)
;;=^5001263
;;^UTILITY(U,$J,358.3,32391,0)
;;=C18.9^^99^1338^4
;;^UTILITY(U,$J,358.3,32391,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32391,1,3,0)
;;=3^Malignant neoplasm of colon, unspecified
;;^UTILITY(U,$J,358.3,32391,1,4,0)
;;=4^C18.9
;;^UTILITY(U,$J,358.3,32391,2)
;;=^5000929
;;^UTILITY(U,$J,358.3,32392,0)
;;=C15.9^^99^1338^5
;;^UTILITY(U,$J,358.3,32392,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32392,1,3,0)
;;=3^Malignant neoplasm of esophagus, unspecified
;;^UTILITY(U,$J,358.3,32392,1,4,0)
;;=4^C15.9
;;^UTILITY(U,$J,358.3,32392,2)
;;=^5000919
;;^UTILITY(U,$J,358.3,32393,0)
;;=C32.9^^99^1338^6
;;^UTILITY(U,$J,358.3,32393,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32393,1,3,0)
;;=3^Malignant neoplasm of larynx, unspecified
;;^UTILITY(U,$J,358.3,32393,1,4,0)
;;=4^C32.9
;;^UTILITY(U,$J,358.3,32393,2)
;;=^5000956
;;^UTILITY(U,$J,358.3,32394,0)
;;=C34.92^^99^1338^7
;;^UTILITY(U,$J,358.3,32394,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32394,1,3,0)
;;=3^Malignant neoplasm of left bronchus/lung,unspec part
;;^UTILITY(U,$J,358.3,32394,1,4,0)
;;=4^C34.92
;;^UTILITY(U,$J,358.3,32394,2)
;;=^5000968
;;^UTILITY(U,$J,358.3,32395,0)
;;=C50.912^^99^1338^8
;;^UTILITY(U,$J,358.3,32395,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32395,1,3,0)
;;=3^Malignant neoplasm of left female breast,unspec site
;;^UTILITY(U,$J,358.3,32395,1,4,0)
;;=4^C50.912
;;^UTILITY(U,$J,358.3,32395,2)
;;=^5001196
;;^UTILITY(U,$J,358.3,32396,0)
;;=C64.2^^99^1338^9
;;^UTILITY(U,$J,358.3,32396,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32396,1,3,0)
;;=3^Malignant neoplasm of left kidney, except renal pelvis
;;^UTILITY(U,$J,358.3,32396,1,4,0)
;;=4^C64.2
;;^UTILITY(U,$J,358.3,32396,2)
;;=^5001249
;;^UTILITY(U,$J,358.3,32397,0)
;;=C61.^^99^1338^10
;;^UTILITY(U,$J,358.3,32397,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32397,1,3,0)
;;=3^Malignant neoplasm of prostate
;;^UTILITY(U,$J,358.3,32397,1,4,0)
;;=4^C61.
;;^UTILITY(U,$J,358.3,32397,2)
;;=^267239
;;^UTILITY(U,$J,358.3,32398,0)
;;=C34.91^^99^1338^11
;;^UTILITY(U,$J,358.3,32398,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32398,1,3,0)
;;=3^Malignant neoplasm of right bronchus/lung,unspec part
;;^UTILITY(U,$J,358.3,32398,1,4,0)
;;=4^C34.91
;;^UTILITY(U,$J,358.3,32398,2)
;;=^5000967
;;^UTILITY(U,$J,358.3,32399,0)
;;=C50.911^^99^1338^12
;;^UTILITY(U,$J,358.3,32399,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32399,1,3,0)
;;=3^Malignant neoplasm of right female breast,unspec site
;;^UTILITY(U,$J,358.3,32399,1,4,0)
;;=4^C50.911
;;^UTILITY(U,$J,358.3,32399,2)
;;=^5001195
;;^UTILITY(U,$J,358.3,32400,0)
;;=C64.1^^99^1338^13
;;^UTILITY(U,$J,358.3,32400,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32400,1,3,0)
;;=3^Malignant neoplasm of right kidney, except renal pelvis
;;^UTILITY(U,$J,358.3,32400,1,4,0)
;;=4^C64.1
;;^UTILITY(U,$J,358.3,32400,2)
;;=^5001248
;;^UTILITY(U,$J,358.3,32401,0)
;;=C44.99^^99^1338^14
;;^UTILITY(U,$J,358.3,32401,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32401,1,3,0)
;;=3^Malignant neoplasm of skin,Oth Spec
;;^UTILITY(U,$J,358.3,32401,1,4,0)
;;=4^C44.99
;;^UTILITY(U,$J,358.3,32401,2)
;;=^5001094
;;^UTILITY(U,$J,358.3,32402,0)
;;=C79.51^^99^1338^15
;;^UTILITY(U,$J,358.3,32402,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32402,1,3,0)
;;=3^Secondary malignant neoplasm of bone
;;^UTILITY(U,$J,358.3,32402,1,4,0)
;;=4^C79.51
;;^UTILITY(U,$J,358.3,32402,2)
;;=^5001350
;;^UTILITY(U,$J,358.3,32403,0)
;;=C79.52^^99^1338^16
;;^UTILITY(U,$J,358.3,32403,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32403,1,3,0)
;;=3^Secondary malignant neoplasm of bone marrow
;;^UTILITY(U,$J,358.3,32403,1,4,0)
;;=4^C79.52
;;^UTILITY(U,$J,358.3,32403,2)
;;=^5001351
;;^UTILITY(U,$J,358.3,32404,0)
;;=D47.4^^99^1339^29
;;^UTILITY(U,$J,358.3,32404,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32404,1,3,0)
;;=3^Osteomyelofibrosis
;;^UTILITY(U,$J,358.3,32404,1,4,0)
;;=4^D47.4
;;^UTILITY(U,$J,358.3,32404,2)
;;=^5002259
;;^UTILITY(U,$J,358.3,32405,0)
;;=D50.9^^99^1339^1
;;^UTILITY(U,$J,358.3,32405,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32405,1,3,0)
;;=3^Anemia, iron deficiency
;;^UTILITY(U,$J,358.3,32405,1,4,0)
;;=4^D50.9
;;^UTILITY(U,$J,358.3,32405,2)
;;=^5002283
;;^UTILITY(U,$J,358.3,32406,0)
;;=D64.9^^99^1339^2
;;^UTILITY(U,$J,358.3,32406,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32406,1,3,0)
;;=3^Anemia, unspecified
;;^UTILITY(U,$J,358.3,32406,1,4,0)
;;=4^D64.9
;;^UTILITY(U,$J,358.3,32406,2)
;;=^5002351
;;^UTILITY(U,$J,358.3,32407,0)
;;=D75.89^^99^1339^3
;;^UTILITY(U,$J,358.3,32407,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32407,1,3,0)
;;=3^Blood & blood forming organ disease, oth spec
;;^UTILITY(U,$J,358.3,32407,1,4,0)
;;=4^D75.89
;;^UTILITY(U,$J,358.3,32407,2)
;;=^5002392
;;^UTILITY(U,$J,358.3,32408,0)
;;=D89.2^^99^1339^16
;;^UTILITY(U,$J,358.3,32408,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32408,1,3,0)
;;=3^Hypergammaglobulinemia, unspecified
;;^UTILITY(U,$J,358.3,32408,1,4,0)
;;=4^D89.2
;;^UTILITY(U,$J,358.3,32408,2)
;;=^5002455
;;^UTILITY(U,$J,358.3,32409,0)
;;=E03.9^^99^1339^24
;;^UTILITY(U,$J,358.3,32409,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32409,1,3,0)
;;=3^Hypothyroidism, unspecified
;;^UTILITY(U,$J,358.3,32409,1,4,0)
;;=4^E03.9
;;^UTILITY(U,$J,358.3,32409,2)
;;=^5002476
;;^UTILITY(U,$J,358.3,32410,0)
;;=E05.90^^99^1339^30
;;^UTILITY(U,$J,358.3,32410,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32410,1,3,0)
;;=3^Thyrotoxicosis w/o thyrotoxic crisis/storm
;;^UTILITY(U,$J,358.3,32410,1,4,0)
;;=4^E05.90
;;^UTILITY(U,$J,358.3,32410,2)
;;=^5002492
;;^UTILITY(U,$J,358.3,32411,0)
;;=E08.42^^99^1339^10
;;^UTILITY(U,$J,358.3,32411,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32411,1,3,0)
;;=3^DM d/t underlying condition w/ diabetic polyneuropathy
;;^UTILITY(U,$J,358.3,32411,1,4,0)
;;=4^E08.42
;;^UTILITY(U,$J,358.3,32411,2)
;;=^5002524
;;^UTILITY(U,$J,358.3,32412,0)
;;=E09.42^^99^1339^11
;;^UTILITY(U,$J,358.3,32412,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32412,1,3,0)
;;=3^DM drug-induced w/ neurological compl w/ diabetic polyneuropathy
;;^UTILITY(U,$J,358.3,32412,1,4,0)
;;=4^E09.42
;;^UTILITY(U,$J,358.3,32412,2)
;;=^5002566
;;^UTILITY(U,$J,358.3,32413,0)
;;=E10.42^^99^1339^4
;;^UTILITY(U,$J,358.3,32413,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32413,1,3,0)
;;=3^DM Type 1 w/ diabetic polyneuropathy
;;^UTILITY(U,$J,358.3,32413,1,4,0)
;;=4^E10.42
;;^UTILITY(U,$J,358.3,32413,2)
;;=^5002606
;;^UTILITY(U,$J,358.3,32414,0)
;;=E10.65^^99^1339^5
;;^UTILITY(U,$J,358.3,32414,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32414,1,3,0)
;;=3^DM Type 1 w/ hyperglycemia
;;^UTILITY(U,$J,358.3,32414,1,4,0)
;;=4^E10.65
;;^UTILITY(U,$J,358.3,32414,2)
;;=^5002623
;;^UTILITY(U,$J,358.3,32415,0)
;;=E10.9^^99^1339^6
;;^UTILITY(U,$J,358.3,32415,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32415,1,3,0)
;;=3^DM Type 1 w/o complications
;;^UTILITY(U,$J,358.3,32415,1,4,0)
;;=4^E10.9
;;^UTILITY(U,$J,358.3,32415,2)
;;=^5002626
;;^UTILITY(U,$J,358.3,32416,0)
;;=E11.42^^99^1339^7
;;^UTILITY(U,$J,358.3,32416,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32416,1,3,0)
;;=3^DM Type 2 w/ diabetic polyneuropathy
;;^UTILITY(U,$J,358.3,32416,1,4,0)
;;=4^E11.42
;;^UTILITY(U,$J,358.3,32416,2)
;;=^5002646
;;^UTILITY(U,$J,358.3,32417,0)
;;=E11.65^^99^1339^8
;;^UTILITY(U,$J,358.3,32417,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32417,1,3,0)
;;=3^DM Type 2 w/ hyperglycemia
;;^UTILITY(U,$J,358.3,32417,1,4,0)
;;=4^E11.65
;;^UTILITY(U,$J,358.3,32417,2)
;;=^5002663
;;^UTILITY(U,$J,358.3,32418,0)
;;=E11.9^^99^1339^9
;;^UTILITY(U,$J,358.3,32418,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32418,1,3,0)
;;=3^DM Type 2 w/o complications
;;^UTILITY(U,$J,358.3,32418,1,4,0)
;;=4^E11.9
;;^UTILITY(U,$J,358.3,32418,2)
;;=^5002666
;;^UTILITY(U,$J,358.3,32419,0)
;;=E13.42^^99^1339^12
;;^UTILITY(U,$J,358.3,32419,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32419,1,3,0)
;;=3^DM oth w/ diabetic polyneuropathy
;;^UTILITY(U,$J,358.3,32419,1,4,0)
;;=4^E13.42
;;^UTILITY(U,$J,358.3,32419,2)
;;=^5002686
;;^UTILITY(U,$J,358.3,32420,0)
;;=E16.2^^99^1339^22
;;^UTILITY(U,$J,358.3,32420,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32420,1,3,0)
;;=3^Hypoglycemia, unspecified
;;^UTILITY(U,$J,358.3,32420,1,4,0)
;;=4^E16.2
;;^UTILITY(U,$J,358.3,32420,2)
;;=^5002708
;;^UTILITY(U,$J,358.3,32421,0)
;;=E46.^^99^1339^26
;;^UTILITY(U,$J,358.3,32421,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32421,1,3,0)
;;=3^Malnutrition, protein-calorie, unspec
;;^UTILITY(U,$J,358.3,32421,1,4,0)
;;=4^E46.
;;^UTILITY(U,$J,358.3,32421,2)
;;=^5002790
;;^UTILITY(U,$J,358.3,32422,0)
;;=E53.8^^99^1339^31
;;^UTILITY(U,$J,358.3,32422,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32422,1,3,0)
;;=3^Vitamin B group deficiency
;;^UTILITY(U,$J,358.3,32422,1,4,0)
;;=4^E53.8
;;^UTILITY(U,$J,358.3,32422,2)
;;=^5002797
;;^UTILITY(U,$J,358.3,32423,0)
;;=E66.01^^99^1339^27
;;^UTILITY(U,$J,358.3,32423,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32423,1,3,0)
;;=3^Obesity, morbid
;;^UTILITY(U,$J,358.3,32423,1,4,0)
;;=4^E66.01
;;^UTILITY(U,$J,358.3,32423,2)
;;=^5002826
;;^UTILITY(U,$J,358.3,32424,0)
;;=E66.9^^99^1339^28
;;^UTILITY(U,$J,358.3,32424,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32424,1,3,0)
;;=3^Obesity, unspecified
;;^UTILITY(U,$J,358.3,32424,1,4,0)
;;=4^E66.9
;;^UTILITY(U,$J,358.3,32424,2)
;;=^5002832
;;^UTILITY(U,$J,358.3,32425,0)
;;=E74.39^^99^1339^25
;;^UTILITY(U,$J,358.3,32425,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32425,1,3,0)
;;=3^Intestinal carbohydrate absorption disorder, other
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0CW 19748 printed Sep 23, 2025@19:22:11 Page 2
IBDEI0CW ; ; 03-MAY-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 03, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,32356,1,4,0)
+2 ;;=4^L20.89
+3 ;;^UTILITY(U,$J,358.3,32356,2)
+4 ;;=^5009112
+5 ;;^UTILITY(U,$J,358.3,32357,0)
+6 ;;=L25.9^^97^1335^15
+7 ;;^UTILITY(U,$J,358.3,32357,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,32357,1,3,0)
+10 ;;=3^Contact Dermatitis,Unspec
+11 ;;^UTILITY(U,$J,358.3,32357,1,4,0)
+12 ;;=4^L25.9
+13 ;;^UTILITY(U,$J,358.3,32357,2)
+14 ;;=^5133647
+15 ;;^UTILITY(U,$J,358.3,32358,0)
+16 ;;=L40.0^^97^1335^16
+17 ;;^UTILITY(U,$J,358.3,32358,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,32358,1,3,0)
+20 ;;=3^Psoriasis
+21 ;;^UTILITY(U,$J,358.3,32358,1,4,0)
+22 ;;=4^L40.0
+23 ;;^UTILITY(U,$J,358.3,32358,2)
+24 ;;=^5009160
+25 ;;^UTILITY(U,$J,358.3,32359,0)
+26 ;;=L29.9^^97^1335^17
+27 ;;^UTILITY(U,$J,358.3,32359,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,32359,1,3,0)
+30 ;;=3^Pruritus
+31 ;;^UTILITY(U,$J,358.3,32359,1,4,0)
+32 ;;=4^L29.9
+33 ;;^UTILITY(U,$J,358.3,32359,2)
+34 ;;=^5009153
+35 ;;^UTILITY(U,$J,358.3,32360,0)
+36 ;;=L85.3^^97^1335^18
+37 ;;^UTILITY(U,$J,358.3,32360,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,32360,1,3,0)
+40 ;;=3^Xerosis
+41 ;;^UTILITY(U,$J,358.3,32360,1,4,0)
+42 ;;=4^L85.3
+43 ;;^UTILITY(U,$J,358.3,32360,2)
+44 ;;=^5009323
+45 ;;^UTILITY(U,$J,358.3,32361,0)
+46 ;;=L30.2^^97^1335^19
+47 ;;^UTILITY(U,$J,358.3,32361,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,32361,1,3,0)
+50 ;;=3^Cutaneous Autosensitization/ld
+51 ;;^UTILITY(U,$J,358.3,32361,1,4,0)
+52 ;;=4^L30.2
+53 ;;^UTILITY(U,$J,358.3,32361,2)
+54 ;;=^5009155
+55 ;;^UTILITY(U,$J,358.3,32362,0)
+56 ;;=L72.0^^97^1335^20
+57 ;;^UTILITY(U,$J,358.3,32362,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,32362,1,3,0)
+60 ;;=3^Epidermal Cyst
+61 ;;^UTILITY(U,$J,358.3,32362,1,4,0)
+62 ;;=4^L72.0
+63 ;;^UTILITY(U,$J,358.3,32362,2)
+64 ;;=^5009277
+65 ;;^UTILITY(U,$J,358.3,32363,0)
+66 ;;=L73.9^^97^1335^21
+67 ;;^UTILITY(U,$J,358.3,32363,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,32363,1,3,0)
+70 ;;=3^Follicular Disorder/Folliculitis
+71 ;;^UTILITY(U,$J,358.3,32363,1,4,0)
+72 ;;=4^L73.9
+73 ;;^UTILITY(U,$J,358.3,32363,2)
+74 ;;=^5009286
+75 ;;^UTILITY(U,$J,358.3,32364,0)
+76 ;;=L70.0^^97^1335^22
+77 ;;^UTILITY(U,$J,358.3,32364,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,32364,1,3,0)
+80 ;;=3^Acne
+81 ;;^UTILITY(U,$J,358.3,32364,1,4,0)
+82 ;;=4^L70.0
+83 ;;^UTILITY(U,$J,358.3,32364,2)
+84 ;;=^5009268
+85 ;;^UTILITY(U,$J,358.3,32365,0)
+86 ;;=L71.8^^97^1335^23
+87 ;;^UTILITY(U,$J,358.3,32365,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,32365,1,3,0)
+90 ;;=3^Rosacea
+91 ;;^UTILITY(U,$J,358.3,32365,1,4,0)
+92 ;;=4^L71.8
+93 ;;^UTILITY(U,$J,358.3,32365,2)
+94 ;;=^5009275
+95 ;;^UTILITY(U,$J,358.3,32366,0)
+96 ;;=L91.0^^97^1335^24
+97 ;;^UTILITY(U,$J,358.3,32366,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,32366,1,3,0)
+100 ;;=3^Hypertrophic Scar
+101 ;;^UTILITY(U,$J,358.3,32366,1,4,0)
+102 ;;=4^L91.0
+103 ;;^UTILITY(U,$J,358.3,32366,2)
+104 ;;=^5009459
+105 ;;^UTILITY(U,$J,358.3,32367,0)
+106 ;;=L91.8^^97^1335^25
+107 ;;^UTILITY(U,$J,358.3,32367,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,32367,1,3,0)
+110 ;;=3^Skin Tag/Oth Hypertrophic Disorder of Skin
+111 ;;^UTILITY(U,$J,358.3,32367,1,4,0)
+112 ;;=4^L91.8
+113 ;;^UTILITY(U,$J,358.3,32367,2)
+114 ;;=^5009460
+115 ;;^UTILITY(U,$J,358.3,32368,0)
+116 ;;=I87.2^^97^1335^26
+117 ;;^UTILITY(U,$J,358.3,32368,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,32368,1,3,0)
+120 ;;=3^Stasis Dermatitis/Venous Insufficiency
+121 ;;^UTILITY(U,$J,358.3,32368,1,4,0)
+122 ;;=4^I87.2
+123 ;;^UTILITY(U,$J,358.3,32368,2)
+124 ;;=^5008047
+125 ;;^UTILITY(U,$J,358.3,32369,0)
+126 ;;=D69.8^^97^1335^27
+127 ;;^UTILITY(U,$J,358.3,32369,1,0)
+128 ;;=^358.31IA^4^2
+129 ;;^UTILITY(U,$J,358.3,32369,1,3,0)
+130 ;;=3^Purpura,Hemorrhagic Condition
+131 ;;^UTILITY(U,$J,358.3,32369,1,4,0)
+132 ;;=4^D69.8
+133 ;;^UTILITY(U,$J,358.3,32369,2)
+134 ;;=^88074
+135 ;;^UTILITY(U,$J,358.3,32370,0)
+136 ;;=L08.9^^97^1335^28
+137 ;;^UTILITY(U,$J,358.3,32370,1,0)
+138 ;;=^358.31IA^4^2
+139 ;;^UTILITY(U,$J,358.3,32370,1,3,0)
+140 ;;=3^Pyoderma
+141 ;;^UTILITY(U,$J,358.3,32370,1,4,0)
+142 ;;=4^L08.9
+143 ;;^UTILITY(U,$J,358.3,32370,2)
+144 ;;=^5009082
+145 ;;^UTILITY(U,$J,358.3,32371,0)
+146 ;;=L01.00^^97^1335^29
+147 ;;^UTILITY(U,$J,358.3,32371,1,0)
+148 ;;=^358.31IA^4^2
+149 ;;^UTILITY(U,$J,358.3,32371,1,3,0)
+150 ;;=3^Impetigo
+151 ;;^UTILITY(U,$J,358.3,32371,1,4,0)
+152 ;;=4^L01.00
+153 ;;^UTILITY(U,$J,358.3,32371,2)
+154 ;;=^5008938
+155 ;;^UTILITY(U,$J,358.3,32372,0)
+156 ;;=L03.90^^97^1335^30
+157 ;;^UTILITY(U,$J,358.3,32372,1,0)
+158 ;;=^358.31IA^4^2
+159 ;;^UTILITY(U,$J,358.3,32372,1,3,0)
+160 ;;=3^Cellulitis
+161 ;;^UTILITY(U,$J,358.3,32372,1,4,0)
+162 ;;=4^L03.90
+163 ;;^UTILITY(U,$J,358.3,32372,2)
+164 ;;=^5009067
+165 ;;^UTILITY(U,$J,358.3,32373,0)
+166 ;;=Z79.1^^97^1335^31
+167 ;;^UTILITY(U,$J,358.3,32373,1,0)
+168 ;;=^358.31IA^4^2
+169 ;;^UTILITY(U,$J,358.3,32373,1,3,0)
+170 ;;=3^Long Term Use NSAID/Oth Health Status
+171 ;;^UTILITY(U,$J,358.3,32373,1,4,0)
+172 ;;=4^Z79.1
+173 ;;^UTILITY(U,$J,358.3,32373,2)
+174 ;;=^5063332
+175 ;;^UTILITY(U,$J,358.3,32374,0)
+176 ;;=Z79.899^^97^1335^32
+177 ;;^UTILITY(U,$J,358.3,32374,1,0)
+178 ;;=^358.31IA^4^2
+179 ;;^UTILITY(U,$J,358.3,32374,1,3,0)
+180 ;;=3^Long Term Use Oth Drug
+181 ;;^UTILITY(U,$J,358.3,32374,1,4,0)
+182 ;;=4^Z79.899
+183 ;;^UTILITY(U,$J,358.3,32374,2)
+184 ;;=^5063343
+185 ;;^UTILITY(U,$J,358.3,32375,0)
+186 ;;=Z80.8^^97^1335^33
+187 ;;^UTILITY(U,$J,358.3,32375,1,0)
+188 ;;=^358.31IA^4^2
+189 ;;^UTILITY(U,$J,358.3,32375,1,3,0)
+190 ;;=3^Family Hx of Melanoma
+191 ;;^UTILITY(U,$J,358.3,32375,1,4,0)
+192 ;;=4^Z80.8
+193 ;;^UTILITY(U,$J,358.3,32375,2)
+194 ;;=^5063356
+195 ;;^UTILITY(U,$J,358.3,32376,0)
+196 ;;=Z48.817^^97^1335^34
+197 ;;^UTILITY(U,$J,358.3,32376,1,0)
+198 ;;=^358.31IA^4^2
+199 ;;^UTILITY(U,$J,358.3,32376,1,3,0)
+200 ;;=3^Surgical Aftercare Skin/Subcutaneous Tissue
+201 ;;^UTILITY(U,$J,358.3,32376,1,4,0)
+202 ;;=4^Z48.817
+203 ;;^UTILITY(U,$J,358.3,32376,2)
+204 ;;=^5063054
+205 ;;^UTILITY(U,$J,358.3,32377,0)
+206 ;;=R99.^^97^1335^35
+207 ;;^UTILITY(U,$J,358.3,32377,1,0)
+208 ;;=^358.31IA^4^2
+209 ;;^UTILITY(U,$J,358.3,32377,1,3,0)
+210 ;;=3^Dead Unknown Mortality
+211 ;;^UTILITY(U,$J,358.3,32377,1,4,0)
+212 ;;=4^R99.
+213 ;;^UTILITY(U,$J,358.3,32377,2)
+214 ;;=^5019750
+215 ;;^UTILITY(U,$J,358.3,32378,0)
+216 ;;=Z85.9^^97^1335^36
+217 ;;^UTILITY(U,$J,358.3,32378,1,0)
+218 ;;=^358.31IA^4^2
+219 ;;^UTILITY(U,$J,358.3,32378,1,3,0)
+220 ;;=3^Personal Hx of Unspec Neoplasm/Cancer
+221 ;;^UTILITY(U,$J,358.3,32378,1,4,0)
+222 ;;=4^Z85.9
+223 ;;^UTILITY(U,$J,358.3,32378,2)
+224 ;;=^5063452
+225 ;;^UTILITY(U,$J,358.3,32379,0)
+226 ;;=C79.9^^97^1335^37
+227 ;;^UTILITY(U,$J,358.3,32379,1,0)
+228 ;;=^358.31IA^4^2
+229 ;;^UTILITY(U,$J,358.3,32379,1,3,0)
+230 ;;=3^Metastatic Cancer Unspec
+231 ;;^UTILITY(U,$J,358.3,32379,1,4,0)
+232 ;;=4^C79.9
+233 ;;^UTILITY(U,$J,358.3,32379,2)
+234 ;;=^5133344
+235 ;;^UTILITY(U,$J,358.3,32380,0)
+236 ;;=Q3014^^98^1336^1^^^^1
+237 ;;^UTILITY(U,$J,358.3,32380,1,0)
+238 ;;=^358.31IA^3^2
+239 ;;^UTILITY(U,$J,358.3,32380,1,2,0)
+240 ;;=2^Q3014
+241 ;;^UTILITY(U,$J,358.3,32380,1,3,0)
+242 ;;=3^Telehealth Fac Fee-Pt Site
+243 ;;^UTILITY(U,$J,358.3,32381,0)
+244 ;;=B19.10^^99^1337^1
+245 ;;^UTILITY(U,$J,358.3,32381,1,0)
+246 ;;=^358.31IA^4^2
+247 ;;^UTILITY(U,$J,358.3,32381,1,3,0)
+248 ;;=3^Hepatitis B w/o Hepatic Coma
+249 ;;^UTILITY(U,$J,358.3,32381,1,4,0)
+250 ;;=4^B19.10
+251 ;;^UTILITY(U,$J,358.3,32381,2)
+252 ;;=^5000552
+253 ;;^UTILITY(U,$J,358.3,32382,0)
+254 ;;=B17.10^^99^1337^2
+255 ;;^UTILITY(U,$J,358.3,32382,1,0)
+256 ;;=^358.31IA^4^2
+257 ;;^UTILITY(U,$J,358.3,32382,1,3,0)
+258 ;;=3^Hepatitis C w/o Hepatic Coma,Acute
+259 ;;^UTILITY(U,$J,358.3,32382,1,4,0)
+260 ;;=4^B17.10
+261 ;;^UTILITY(U,$J,358.3,32382,2)
+262 ;;=^5000542
+263 ;;^UTILITY(U,$J,358.3,32383,0)
+264 ;;=B18.2^^99^1337^3
+265 ;;^UTILITY(U,$J,358.3,32383,1,0)
+266 ;;=^358.31IA^4^2
+267 ;;^UTILITY(U,$J,358.3,32383,1,3,0)
+268 ;;=3^Hepatitis C,Chr
+269 ;;^UTILITY(U,$J,358.3,32383,1,4,0)
+270 ;;=4^B18.2
+271 ;;^UTILITY(U,$J,358.3,32383,2)
+272 ;;=^5000548
+273 ;;^UTILITY(U,$J,358.3,32384,0)
+274 ;;=B35.6^^99^1337^4
+275 ;;^UTILITY(U,$J,358.3,32384,1,0)
+276 ;;=^358.31IA^4^2
+277 ;;^UTILITY(U,$J,358.3,32384,1,3,0)
+278 ;;=3^Tinea Cruris
+279 ;;^UTILITY(U,$J,358.3,32384,1,4,0)
+280 ;;=4^B35.6
+281 ;;^UTILITY(U,$J,358.3,32384,2)
+282 ;;=^119711
+283 ;;^UTILITY(U,$J,358.3,32385,0)
+284 ;;=B35.3^^99^1337^5
+285 ;;^UTILITY(U,$J,358.3,32385,1,0)
+286 ;;=^358.31IA^4^2
+287 ;;^UTILITY(U,$J,358.3,32385,1,3,0)
+288 ;;=3^Tinea Pedis
+289 ;;^UTILITY(U,$J,358.3,32385,1,4,0)
+290 ;;=4^B35.3
+291 ;;^UTILITY(U,$J,358.3,32385,2)
+292 ;;=^119732
+293 ;;^UTILITY(U,$J,358.3,32386,0)
+294 ;;=B97.89^^99^1337^6
+295 ;;^UTILITY(U,$J,358.3,32386,1,0)
+296 ;;=^358.31IA^4^2
+297 ;;^UTILITY(U,$J,358.3,32386,1,3,0)
+298 ;;=3^Viral Agents as the Cause of Diseases Classified Elsewhere
+299 ;;^UTILITY(U,$J,358.3,32386,1,4,0)
+300 ;;=4^B97.89
+301 ;;^UTILITY(U,$J,358.3,32386,2)
+302 ;;=^5000879
+303 ;;^UTILITY(U,$J,358.3,32387,0)
+304 ;;=B02.9^^99^1337^7
+305 ;;^UTILITY(U,$J,358.3,32387,1,0)
+306 ;;=^358.31IA^4^2
+307 ;;^UTILITY(U,$J,358.3,32387,1,3,0)
+308 ;;=3^Zoster w/o Complications
+309 ;;^UTILITY(U,$J,358.3,32387,1,4,0)
+310 ;;=4^B02.9
+311 ;;^UTILITY(U,$J,358.3,32387,2)
+312 ;;=^5000501
+313 ;;^UTILITY(U,$J,358.3,32388,0)
+314 ;;=C44.91^^99^1338^1
+315 ;;^UTILITY(U,$J,358.3,32388,1,0)
+316 ;;=^358.31IA^4^2
+317 ;;^UTILITY(U,$J,358.3,32388,1,3,0)
+318 ;;=3^Basal cell carcinoma of skin, unspecified
+319 ;;^UTILITY(U,$J,358.3,32388,1,4,0)
+320 ;;=4^C44.91
+321 ;;^UTILITY(U,$J,358.3,32388,2)
+322 ;;=^5001092
+323 ;;^UTILITY(U,$J,358.3,32389,0)
+324 ;;=D17.9^^99^1338^2
+325 ;;^UTILITY(U,$J,358.3,32389,1,0)
+326 ;;=^358.31IA^4^2
+327 ;;^UTILITY(U,$J,358.3,32389,1,3,0)
+328 ;;=3^Benign lipomatous neoplasm, unspecified
+329 ;;^UTILITY(U,$J,358.3,32389,1,4,0)
+330 ;;=4^D17.9
+331 ;;^UTILITY(U,$J,358.3,32389,2)
+332 ;;=^5002020
+333 ;;^UTILITY(U,$J,358.3,32390,0)
+334 ;;=C67.9^^99^1338^3
+335 ;;^UTILITY(U,$J,358.3,32390,1,0)
+336 ;;=^358.31IA^4^2
+337 ;;^UTILITY(U,$J,358.3,32390,1,3,0)
+338 ;;=3^Malignant neoplasm of bladder, unspecified
+339 ;;^UTILITY(U,$J,358.3,32390,1,4,0)
+340 ;;=4^C67.9
+341 ;;^UTILITY(U,$J,358.3,32390,2)
+342 ;;=^5001263
+343 ;;^UTILITY(U,$J,358.3,32391,0)
+344 ;;=C18.9^^99^1338^4
+345 ;;^UTILITY(U,$J,358.3,32391,1,0)
+346 ;;=^358.31IA^4^2
+347 ;;^UTILITY(U,$J,358.3,32391,1,3,0)
+348 ;;=3^Malignant neoplasm of colon, unspecified
+349 ;;^UTILITY(U,$J,358.3,32391,1,4,0)
+350 ;;=4^C18.9
+351 ;;^UTILITY(U,$J,358.3,32391,2)
+352 ;;=^5000929
+353 ;;^UTILITY(U,$J,358.3,32392,0)
+354 ;;=C15.9^^99^1338^5
+355 ;;^UTILITY(U,$J,358.3,32392,1,0)
+356 ;;=^358.31IA^4^2
+357 ;;^UTILITY(U,$J,358.3,32392,1,3,0)
+358 ;;=3^Malignant neoplasm of esophagus, unspecified
+359 ;;^UTILITY(U,$J,358.3,32392,1,4,0)
+360 ;;=4^C15.9
+361 ;;^UTILITY(U,$J,358.3,32392,2)
+362 ;;=^5000919
+363 ;;^UTILITY(U,$J,358.3,32393,0)
+364 ;;=C32.9^^99^1338^6
+365 ;;^UTILITY(U,$J,358.3,32393,1,0)
+366 ;;=^358.31IA^4^2
+367 ;;^UTILITY(U,$J,358.3,32393,1,3,0)
+368 ;;=3^Malignant neoplasm of larynx, unspecified
+369 ;;^UTILITY(U,$J,358.3,32393,1,4,0)
+370 ;;=4^C32.9
+371 ;;^UTILITY(U,$J,358.3,32393,2)
+372 ;;=^5000956
+373 ;;^UTILITY(U,$J,358.3,32394,0)
+374 ;;=C34.92^^99^1338^7
+375 ;;^UTILITY(U,$J,358.3,32394,1,0)
+376 ;;=^358.31IA^4^2
+377 ;;^UTILITY(U,$J,358.3,32394,1,3,0)
+378 ;;=3^Malignant neoplasm of left bronchus/lung,unspec part
+379 ;;^UTILITY(U,$J,358.3,32394,1,4,0)
+380 ;;=4^C34.92
+381 ;;^UTILITY(U,$J,358.3,32394,2)
+382 ;;=^5000968
+383 ;;^UTILITY(U,$J,358.3,32395,0)
+384 ;;=C50.912^^99^1338^8
+385 ;;^UTILITY(U,$J,358.3,32395,1,0)
+386 ;;=^358.31IA^4^2
+387 ;;^UTILITY(U,$J,358.3,32395,1,3,0)
+388 ;;=3^Malignant neoplasm of left female breast,unspec site
+389 ;;^UTILITY(U,$J,358.3,32395,1,4,0)
+390 ;;=4^C50.912
+391 ;;^UTILITY(U,$J,358.3,32395,2)
+392 ;;=^5001196
+393 ;;^UTILITY(U,$J,358.3,32396,0)
+394 ;;=C64.2^^99^1338^9
+395 ;;^UTILITY(U,$J,358.3,32396,1,0)
+396 ;;=^358.31IA^4^2
+397 ;;^UTILITY(U,$J,358.3,32396,1,3,0)
+398 ;;=3^Malignant neoplasm of left kidney, except renal pelvis
+399 ;;^UTILITY(U,$J,358.3,32396,1,4,0)
+400 ;;=4^C64.2
+401 ;;^UTILITY(U,$J,358.3,32396,2)
+402 ;;=^5001249
+403 ;;^UTILITY(U,$J,358.3,32397,0)
+404 ;;=C61.^^99^1338^10
+405 ;;^UTILITY(U,$J,358.3,32397,1,0)
+406 ;;=^358.31IA^4^2
+407 ;;^UTILITY(U,$J,358.3,32397,1,3,0)
+408 ;;=3^Malignant neoplasm of prostate
+409 ;;^UTILITY(U,$J,358.3,32397,1,4,0)
+410 ;;=4^C61.
+411 ;;^UTILITY(U,$J,358.3,32397,2)
+412 ;;=^267239
+413 ;;^UTILITY(U,$J,358.3,32398,0)
+414 ;;=C34.91^^99^1338^11
+415 ;;^UTILITY(U,$J,358.3,32398,1,0)
+416 ;;=^358.31IA^4^2
+417 ;;^UTILITY(U,$J,358.3,32398,1,3,0)
+418 ;;=3^Malignant neoplasm of right bronchus/lung,unspec part
+419 ;;^UTILITY(U,$J,358.3,32398,1,4,0)
+420 ;;=4^C34.91
+421 ;;^UTILITY(U,$J,358.3,32398,2)
+422 ;;=^5000967
+423 ;;^UTILITY(U,$J,358.3,32399,0)
+424 ;;=C50.911^^99^1338^12
+425 ;;^UTILITY(U,$J,358.3,32399,1,0)
+426 ;;=^358.31IA^4^2
+427 ;;^UTILITY(U,$J,358.3,32399,1,3,0)
+428 ;;=3^Malignant neoplasm of right female breast,unspec site
+429 ;;^UTILITY(U,$J,358.3,32399,1,4,0)
+430 ;;=4^C50.911
+431 ;;^UTILITY(U,$J,358.3,32399,2)
+432 ;;=^5001195
+433 ;;^UTILITY(U,$J,358.3,32400,0)
+434 ;;=C64.1^^99^1338^13
+435 ;;^UTILITY(U,$J,358.3,32400,1,0)
+436 ;;=^358.31IA^4^2
+437 ;;^UTILITY(U,$J,358.3,32400,1,3,0)
+438 ;;=3^Malignant neoplasm of right kidney, except renal pelvis
+439 ;;^UTILITY(U,$J,358.3,32400,1,4,0)
+440 ;;=4^C64.1
+441 ;;^UTILITY(U,$J,358.3,32400,2)
+442 ;;=^5001248
+443 ;;^UTILITY(U,$J,358.3,32401,0)
+444 ;;=C44.99^^99^1338^14
+445 ;;^UTILITY(U,$J,358.3,32401,1,0)
+446 ;;=^358.31IA^4^2
+447 ;;^UTILITY(U,$J,358.3,32401,1,3,0)
+448 ;;=3^Malignant neoplasm of skin,Oth Spec
+449 ;;^UTILITY(U,$J,358.3,32401,1,4,0)
+450 ;;=4^C44.99
+451 ;;^UTILITY(U,$J,358.3,32401,2)
+452 ;;=^5001094
+453 ;;^UTILITY(U,$J,358.3,32402,0)
+454 ;;=C79.51^^99^1338^15
+455 ;;^UTILITY(U,$J,358.3,32402,1,0)
+456 ;;=^358.31IA^4^2
+457 ;;^UTILITY(U,$J,358.3,32402,1,3,0)
+458 ;;=3^Secondary malignant neoplasm of bone
+459 ;;^UTILITY(U,$J,358.3,32402,1,4,0)
+460 ;;=4^C79.51
+461 ;;^UTILITY(U,$J,358.3,32402,2)
+462 ;;=^5001350
+463 ;;^UTILITY(U,$J,358.3,32403,0)
+464 ;;=C79.52^^99^1338^16
+465 ;;^UTILITY(U,$J,358.3,32403,1,0)
+466 ;;=^358.31IA^4^2
+467 ;;^UTILITY(U,$J,358.3,32403,1,3,0)
+468 ;;=3^Secondary malignant neoplasm of bone marrow
+469 ;;^UTILITY(U,$J,358.3,32403,1,4,0)
+470 ;;=4^C79.52
+471 ;;^UTILITY(U,$J,358.3,32403,2)
+472 ;;=^5001351
+473 ;;^UTILITY(U,$J,358.3,32404,0)
+474 ;;=D47.4^^99^1339^29
+475 ;;^UTILITY(U,$J,358.3,32404,1,0)
+476 ;;=^358.31IA^4^2
+477 ;;^UTILITY(U,$J,358.3,32404,1,3,0)
+478 ;;=3^Osteomyelofibrosis
+479 ;;^UTILITY(U,$J,358.3,32404,1,4,0)
+480 ;;=4^D47.4
+481 ;;^UTILITY(U,$J,358.3,32404,2)
+482 ;;=^5002259
+483 ;;^UTILITY(U,$J,358.3,32405,0)
+484 ;;=D50.9^^99^1339^1
+485 ;;^UTILITY(U,$J,358.3,32405,1,0)
+486 ;;=^358.31IA^4^2
+487 ;;^UTILITY(U,$J,358.3,32405,1,3,0)
+488 ;;=3^Anemia, iron deficiency
+489 ;;^UTILITY(U,$J,358.3,32405,1,4,0)
+490 ;;=4^D50.9
+491 ;;^UTILITY(U,$J,358.3,32405,2)
+492 ;;=^5002283
+493 ;;^UTILITY(U,$J,358.3,32406,0)
+494 ;;=D64.9^^99^1339^2
+495 ;;^UTILITY(U,$J,358.3,32406,1,0)
+496 ;;=^358.31IA^4^2
+497 ;;^UTILITY(U,$J,358.3,32406,1,3,0)
+498 ;;=3^Anemia, unspecified
+499 ;;^UTILITY(U,$J,358.3,32406,1,4,0)
+500 ;;=4^D64.9
+501 ;;^UTILITY(U,$J,358.3,32406,2)
+502 ;;=^5002351
+503 ;;^UTILITY(U,$J,358.3,32407,0)
+504 ;;=D75.89^^99^1339^3
+505 ;;^UTILITY(U,$J,358.3,32407,1,0)
+506 ;;=^358.31IA^4^2
+507 ;;^UTILITY(U,$J,358.3,32407,1,3,0)
+508 ;;=3^Blood & blood forming organ disease, oth spec
+509 ;;^UTILITY(U,$J,358.3,32407,1,4,0)
+510 ;;=4^D75.89
+511 ;;^UTILITY(U,$J,358.3,32407,2)
+512 ;;=^5002392
+513 ;;^UTILITY(U,$J,358.3,32408,0)
+514 ;;=D89.2^^99^1339^16
+515 ;;^UTILITY(U,$J,358.3,32408,1,0)
+516 ;;=^358.31IA^4^2
+517 ;;^UTILITY(U,$J,358.3,32408,1,3,0)
+518 ;;=3^Hypergammaglobulinemia, unspecified
+519 ;;^UTILITY(U,$J,358.3,32408,1,4,0)
+520 ;;=4^D89.2
+521 ;;^UTILITY(U,$J,358.3,32408,2)
+522 ;;=^5002455
+523 ;;^UTILITY(U,$J,358.3,32409,0)
+524 ;;=E03.9^^99^1339^24
+525 ;;^UTILITY(U,$J,358.3,32409,1,0)
+526 ;;=^358.31IA^4^2
+527 ;;^UTILITY(U,$J,358.3,32409,1,3,0)
+528 ;;=3^Hypothyroidism, unspecified
+529 ;;^UTILITY(U,$J,358.3,32409,1,4,0)
+530 ;;=4^E03.9
+531 ;;^UTILITY(U,$J,358.3,32409,2)
+532 ;;=^5002476
+533 ;;^UTILITY(U,$J,358.3,32410,0)
+534 ;;=E05.90^^99^1339^30
+535 ;;^UTILITY(U,$J,358.3,32410,1,0)
+536 ;;=^358.31IA^4^2
+537 ;;^UTILITY(U,$J,358.3,32410,1,3,0)
+538 ;;=3^Thyrotoxicosis w/o thyrotoxic crisis/storm
+539 ;;^UTILITY(U,$J,358.3,32410,1,4,0)
+540 ;;=4^E05.90
+541 ;;^UTILITY(U,$J,358.3,32410,2)
+542 ;;=^5002492
+543 ;;^UTILITY(U,$J,358.3,32411,0)
+544 ;;=E08.42^^99^1339^10
+545 ;;^UTILITY(U,$J,358.3,32411,1,0)
+546 ;;=^358.31IA^4^2
+547 ;;^UTILITY(U,$J,358.3,32411,1,3,0)
+548 ;;=3^DM d/t underlying condition w/ diabetic polyneuropathy
+549 ;;^UTILITY(U,$J,358.3,32411,1,4,0)
+550 ;;=4^E08.42
+551 ;;^UTILITY(U,$J,358.3,32411,2)
+552 ;;=^5002524
+553 ;;^UTILITY(U,$J,358.3,32412,0)
+554 ;;=E09.42^^99^1339^11
+555 ;;^UTILITY(U,$J,358.3,32412,1,0)
+556 ;;=^358.31IA^4^2
+557 ;;^UTILITY(U,$J,358.3,32412,1,3,0)
+558 ;;=3^DM drug-induced w/ neurological compl w/ diabetic polyneuropathy
+559 ;;^UTILITY(U,$J,358.3,32412,1,4,0)
+560 ;;=4^E09.42
+561 ;;^UTILITY(U,$J,358.3,32412,2)
+562 ;;=^5002566
+563 ;;^UTILITY(U,$J,358.3,32413,0)
+564 ;;=E10.42^^99^1339^4
+565 ;;^UTILITY(U,$J,358.3,32413,1,0)
+566 ;;=^358.31IA^4^2
+567 ;;^UTILITY(U,$J,358.3,32413,1,3,0)
+568 ;;=3^DM Type 1 w/ diabetic polyneuropathy
+569 ;;^UTILITY(U,$J,358.3,32413,1,4,0)
+570 ;;=4^E10.42
+571 ;;^UTILITY(U,$J,358.3,32413,2)
+572 ;;=^5002606
+573 ;;^UTILITY(U,$J,358.3,32414,0)
+574 ;;=E10.65^^99^1339^5
+575 ;;^UTILITY(U,$J,358.3,32414,1,0)
+576 ;;=^358.31IA^4^2
+577 ;;^UTILITY(U,$J,358.3,32414,1,3,0)
+578 ;;=3^DM Type 1 w/ hyperglycemia
+579 ;;^UTILITY(U,$J,358.3,32414,1,4,0)
+580 ;;=4^E10.65
+581 ;;^UTILITY(U,$J,358.3,32414,2)
+582 ;;=^5002623
+583 ;;^UTILITY(U,$J,358.3,32415,0)
+584 ;;=E10.9^^99^1339^6
+585 ;;^UTILITY(U,$J,358.3,32415,1,0)
+586 ;;=^358.31IA^4^2
+587 ;;^UTILITY(U,$J,358.3,32415,1,3,0)
+588 ;;=3^DM Type 1 w/o complications
+589 ;;^UTILITY(U,$J,358.3,32415,1,4,0)
+590 ;;=4^E10.9
+591 ;;^UTILITY(U,$J,358.3,32415,2)
+592 ;;=^5002626
+593 ;;^UTILITY(U,$J,358.3,32416,0)
+594 ;;=E11.42^^99^1339^7
+595 ;;^UTILITY(U,$J,358.3,32416,1,0)
+596 ;;=^358.31IA^4^2
+597 ;;^UTILITY(U,$J,358.3,32416,1,3,0)
+598 ;;=3^DM Type 2 w/ diabetic polyneuropathy
+599 ;;^UTILITY(U,$J,358.3,32416,1,4,0)
+600 ;;=4^E11.42
+601 ;;^UTILITY(U,$J,358.3,32416,2)
+602 ;;=^5002646
+603 ;;^UTILITY(U,$J,358.3,32417,0)
+604 ;;=E11.65^^99^1339^8
+605 ;;^UTILITY(U,$J,358.3,32417,1,0)
+606 ;;=^358.31IA^4^2
+607 ;;^UTILITY(U,$J,358.3,32417,1,3,0)
+608 ;;=3^DM Type 2 w/ hyperglycemia
+609 ;;^UTILITY(U,$J,358.3,32417,1,4,0)
+610 ;;=4^E11.65
+611 ;;^UTILITY(U,$J,358.3,32417,2)
+612 ;;=^5002663
+613 ;;^UTILITY(U,$J,358.3,32418,0)
+614 ;;=E11.9^^99^1339^9
+615 ;;^UTILITY(U,$J,358.3,32418,1,0)
+616 ;;=^358.31IA^4^2
+617 ;;^UTILITY(U,$J,358.3,32418,1,3,0)
+618 ;;=3^DM Type 2 w/o complications
+619 ;;^UTILITY(U,$J,358.3,32418,1,4,0)
+620 ;;=4^E11.9
+621 ;;^UTILITY(U,$J,358.3,32418,2)
+622 ;;=^5002666
+623 ;;^UTILITY(U,$J,358.3,32419,0)
+624 ;;=E13.42^^99^1339^12
+625 ;;^UTILITY(U,$J,358.3,32419,1,0)
+626 ;;=^358.31IA^4^2
+627 ;;^UTILITY(U,$J,358.3,32419,1,3,0)
+628 ;;=3^DM oth w/ diabetic polyneuropathy
+629 ;;^UTILITY(U,$J,358.3,32419,1,4,0)
+630 ;;=4^E13.42
+631 ;;^UTILITY(U,$J,358.3,32419,2)
+632 ;;=^5002686
+633 ;;^UTILITY(U,$J,358.3,32420,0)
+634 ;;=E16.2^^99^1339^22
+635 ;;^UTILITY(U,$J,358.3,32420,1,0)
+636 ;;=^358.31IA^4^2
+637 ;;^UTILITY(U,$J,358.3,32420,1,3,0)
+638 ;;=3^Hypoglycemia, unspecified
+639 ;;^UTILITY(U,$J,358.3,32420,1,4,0)
+640 ;;=4^E16.2
+641 ;;^UTILITY(U,$J,358.3,32420,2)
+642 ;;=^5002708
+643 ;;^UTILITY(U,$J,358.3,32421,0)
+644 ;;=E46.^^99^1339^26
+645 ;;^UTILITY(U,$J,358.3,32421,1,0)
+646 ;;=^358.31IA^4^2
+647 ;;^UTILITY(U,$J,358.3,32421,1,3,0)
+648 ;;=3^Malnutrition, protein-calorie, unspec
+649 ;;^UTILITY(U,$J,358.3,32421,1,4,0)
+650 ;;=4^E46.
+651 ;;^UTILITY(U,$J,358.3,32421,2)
+652 ;;=^5002790
+653 ;;^UTILITY(U,$J,358.3,32422,0)
+654 ;;=E53.8^^99^1339^31
+655 ;;^UTILITY(U,$J,358.3,32422,1,0)
+656 ;;=^358.31IA^4^2
+657 ;;^UTILITY(U,$J,358.3,32422,1,3,0)
+658 ;;=3^Vitamin B group deficiency
+659 ;;^UTILITY(U,$J,358.3,32422,1,4,0)
+660 ;;=4^E53.8
+661 ;;^UTILITY(U,$J,358.3,32422,2)
+662 ;;=^5002797
+663 ;;^UTILITY(U,$J,358.3,32423,0)
+664 ;;=E66.01^^99^1339^27
+665 ;;^UTILITY(U,$J,358.3,32423,1,0)
+666 ;;=^358.31IA^4^2
+667 ;;^UTILITY(U,$J,358.3,32423,1,3,0)
+668 ;;=3^Obesity, morbid
+669 ;;^UTILITY(U,$J,358.3,32423,1,4,0)
+670 ;;=4^E66.01
+671 ;;^UTILITY(U,$J,358.3,32423,2)
+672 ;;=^5002826
+673 ;;^UTILITY(U,$J,358.3,32424,0)
+674 ;;=E66.9^^99^1339^28
+675 ;;^UTILITY(U,$J,358.3,32424,1,0)
+676 ;;=^358.31IA^4^2
+677 ;;^UTILITY(U,$J,358.3,32424,1,3,0)
+678 ;;=3^Obesity, unspecified
+679 ;;^UTILITY(U,$J,358.3,32424,1,4,0)
+680 ;;=4^E66.9
+681 ;;^UTILITY(U,$J,358.3,32424,2)
+682 ;;=^5002832
+683 ;;^UTILITY(U,$J,358.3,32425,0)
+684 ;;=E74.39^^99^1339^25
+685 ;;^UTILITY(U,$J,358.3,32425,1,0)
+686 ;;=^358.31IA^4^2
+687 ;;^UTILITY(U,$J,358.3,32425,1,3,0)
+688 ;;=3^Intestinal carbohydrate absorption disorder, other
